Basic Information
Isoprene Pharmaceuticals, Inc. is an early-stage small-molecule oncology company developing oral therapies for triple-negative breast cancer (TNBC) and other cancers.
Isoprene Pharmaceuticals, Inc.
Delaware,United States of America
unclear
June 19, 2018
--
--
Enterprise Profile
Industrial Sector
Concept
Application Scenarios